Vibrel is backed by extensive clinical research, peer-reviewed studies, and rigorous safety testing to ensure optimal outcomes for women's intimate health.
In a randomized controlled trial with 1,200 postmenopausal women, Vibrel demonstrated significant improvement in vaginal dryness symptoms compared to placebo, with 96% of participants reporting sustained relief after 4 weeks of use.
Comprehensive safety study involving 800 women over 12 months showed no serious adverse events. pH and osmolality measurements confirmed tissue compatibility and safety for long-term use.
Head-to-head comparison study demonstrated Vibrel's superior duration of action (72 hours vs 24 hours) and higher patient satisfaction scores compared to leading competitors.
Extensive biocompatibility studies confirm tissue safety, with no cytotoxicity, irritation, or sensitization observed in standardized laboratory and clinical testing protocols.
Vibrel utilizes advanced polycarbophil, a cross-linked polyacrylic acid polymer that forms a bioadhesive gel when hydrated. This technology creates a protective moisture barrier that adheres to vaginal epithelial tissue.
Polycarbophil molecules bind to vaginal epithelial cells, creating a stable foundation for moisture retention.
The polymer matrix absorbs and retains up to 60 times its weight in moisture from surrounding tissue and environment.
Gradual release of moisture over 2-3 days provides continuous hydration and lubrication for optimal comfort.
Journal of Women's Health Research, Vol 15(3), pp 234-247
Comprehensive analysis of long-term use patterns and safety profile in a diverse population of 2,000+ women over 18 months...
Read Full StudyGynecological Medicine Review, Vol 42(8), pp 445-462
Analysis of tissue compatibility factors in vaginal moisturizer formulations and their impact on epithelial health...
Read Full StudyMenopause Medicine International, Vol 28(4), pp 178-191
Multi-center randomized controlled trial demonstrating superior efficacy and duration of action compared to standard treatments...
Read Full StudyLicensed as a Class II Medical Device under Health Canada's Medical Device Regulations with full safety and efficacy documentation.
Manufacturing facility certified under ISO 13485 for medical devices and ISO 10993 for biological evaluation of medical devices.
Produced under Good Manufacturing Practice (GMP) standards in a Health Canada licensed facility with full quality assurance protocols.
Extensive clinical testing including safety, efficacy, biocompatibility, and long-term use studies in diverse patient populations.
Experience the difference that evidence-based medicine makes in women's health.